Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$27.5 - $37.92 $2.32 Million - $3.19 Million
-84,194 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$26.16 - $63.5 $300,656 - $729,805
-11,493 Reduced 12.01%
84,194 $3.87 Million
Q4 2019

Feb 13, 2020

SELL
$46.96 - $61.67 $2.09 Million - $2.75 Million
-44,599 Reduced 31.79%
95,687 $8.4 Million
Q3 2019

Nov 13, 2019

BUY
$59.47 - $93.1 $2.28 Million - $3.57 Million
38,368 Added 37.65%
140,286 $12.9 Million
Q2 2019

Aug 14, 2019

BUY
$75.84 - $105.21 $825,821 - $1.15 Million
10,889 Added 11.96%
101,918 $13 Million
Q1 2019

May 14, 2019

SELL
$64.44 - $104.11 $476,856 - $770,414
-7,400 Reduced 7.52%
91,029 $14.3 Million
Q4 2018

Feb 13, 2019

BUY
$59.1 - $93.26 $628,883 - $992,379
10,641 Added 12.12%
98,429 $9.76 Million
Q3 2018

Nov 13, 2018

BUY
$88.86 - $117.49 $1.39 Million - $1.83 Million
15,590 Added 21.59%
87,788 $12.8 Million
Q2 2018

Aug 13, 2018

BUY
$99.64 - $127.59 $586,879 - $751,505
5,890 Added 8.88%
72,198 $11.3 Million
Q1 2018

May 14, 2018

BUY
$105.8 - $150.94 $2.03 Million - $2.9 Million
19,215 Added 40.8%
66,308 $11.3 Million
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $2.75 Million - $4.42 Million
33,820 Added 254.8%
47,093 $8.39 Million
Q2 2017

Aug 14, 2017

BUY
N/A
13,273
13,273 $1.39 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $644M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.